https://vitalspanwire.com/news/danegaptide-oral-diabetic-retinopathy-early-studyVitalspan Wireen2026-09-24T21:02:31.046ZDanegaptide paper advances case for testing oral treatment of diabetic retinal diseasehttps://vitalspanwire.com/news/fda-approves-onswik-weekly-insulin-type-2-diabetesVitalspan Wireen2026-09-24T16:02:11.726ZFDA approves Lilly’s once-weekly insulin Onswik for type 2 diabeteshttps://vitalspanwire.com/news/employment-instability-later-life-cognition-studyVitalspan Wireen2026-09-24T11:02:13.505ZEmployment instability linked to poorer later-life cognition in U.S. studyhttps://vitalspanwire.com/news/catestatin-peptide-neurodegeneration-tau-amyloid-mouse-studyVitalspan Wireen2026-09-23T21:02:33.907ZCatestatin peptide reduces neurodegeneration markers in mouse modelshttps://vitalspanwire.com/news/dnl343-als-trial-published-no-slowing-progressionVitalspan Wireen2026-09-23T16:02:12.577ZPublished DNL343 trial finds no slowing of ALS progressionhttps://vitalspanwire.com/news/spinal-bone-density-cognitive-decline-mesa-studyVitalspan Wireen2026-09-23T11:02:33.834ZLower spinal bone density linked to faster cognitive decline in aging study